Clinical Trial Update: Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating postoperative adjuvant chemotherapy with bevacizumab and maintenance bevacizumab following neoadjuvant therapy in epithelial ovarian ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: COMPLETED